Emily Pollock

770 total citations
17 papers, 333 citations indexed

About

Emily Pollock is a scholar working on Immunology, Oncology and Genetics. According to data from OpenAlex, Emily Pollock has authored 17 papers receiving a total of 333 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 6 papers in Oncology and 4 papers in Genetics. Recurrent topics in Emily Pollock's work include Immunotherapy and Immune Responses (6 papers), Immune Cell Function and Interaction (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Emily Pollock is often cited by papers focused on Immunotherapy and Immune Responses (6 papers), Immune Cell Function and Interaction (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Emily Pollock collaborates with scholars based in United Kingdom, Canada and Belgium. Emily Pollock's co-authors include Michael O. Poulter, Arthur Brown, Federica Cappuccini, Adrian V. S. Hill, Irina Redchenko, Stephen M. Stribbling, Timothy Tree, Jeffrey Seow, Katie J. Doores and Rachel M. Tribe and has published in prestigious journals such as Journal of Clinical Oncology, Nature Immunology and Annals of Oncology.

In The Last Decade

Emily Pollock

16 papers receiving 328 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Emily Pollock United Kingdom	10	102	82	81	60	51	17	333
Ning Ding China	12	72 0.7×	27 0.3×	86 1.1×	26 0.4×	15 0.3×	37	466
M Torboli Italy	3	176 1.7×	30 0.4×	124 1.5×	28 0.5×	35 0.7×	3	618
Lan‐Phuong Dao‐Ung Australia	7	151 1.5×	30 0.4×	91 1.1×	45 0.8×	17 0.3×	9	632
Fethia Ben Yebdri Canada	10	164 1.6×	68 0.8×	141 1.7×	19 0.3×	17 0.3×	10	423
C. A. Vedeler Norway	11	79 0.8×	72 0.9×	55 0.7×	47 0.8×	54 1.1×	13	442
Lotta L. E. Koskinen Finland	11	106 1.0×	35 0.4×	50 0.6×	32 0.5×	38 0.7×	17	441
Wesley A. Cheng United States	9	100 1.0×	117 1.4×	46 0.6×	35 0.6×	8 0.2×	17	270
Victoria R. Rendell United States	13	48 0.5×	102 1.2×	96 1.2×	12 0.2×	55 1.1×	30	482
Young Jong Woo South Korea	11	22 0.2×	68 0.8×	69 0.9×	14 0.2×	44 0.9×	53	399
Clara Erice United States	10	60 0.6×	30 0.4×	146 1.8×	14 0.2×	53 1.0×	20	432

Countries citing papers authored by Emily Pollock

Since Specialization

Citations

This map shows the geographic impact of Emily Pollock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Pollock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Pollock more than expected).

Fields of papers citing papers by Emily Pollock

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily Pollock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Pollock. The network helps show where Emily Pollock may publish in the future.

Co-authorship network of co-authors of Emily Pollock

This figure shows the co-authorship network connecting the top 25 collaborators of Emily Pollock. A scholar is included among the top collaborators of Emily Pollock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily Pollock. Emily Pollock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Arif, Sefina, et al.. (2023). Monitoring islet specific immune responses in type 1 diabetes clinical immunotherapy trials. Frontiers in Immunology. 14. 1183909–1183909. 4 indexed citations

McKenzie, Duncan R., Rosalind Graham, Thomas Lechmere, et al.. (2022). Boosting of Waned Humoral and Cellular Responses to SARS-CoV-2 Variants of Concern Among Patients with Cancer. Cancer Research Communications. 2(11). 1449–1461. 1 indexed citations

Österdahl, Marc F., Eleni Christakou, Deborah Hart, et al.. (2022). Concordance of B‐ and T‐cell responses to SARS‐CoV‐2 infection, irrespective of symptoms suggestive of COVID‐19. Journal of Medical Virology. 94(11). 5217–5224. 4 indexed citations

Gee, Sarah, Manju Chandiramani, Jeffrey Seow, et al.. (2021). The legacy of maternal SARS-CoV-2 infection on the immunology of the neonate. Nature Immunology. 22(12). 1490–1502. 74 indexed citations

Arif, Sefina, Irma Pujol‐Autonell, Yogesh Kamra, et al.. (2021). Mapping T Cell Responses to Native and Neo-Islet Antigen Epitopes in at Risk and Type 1 Diabetes Subjects. Frontiers in Immunology. 12. 675746–675746. 13 indexed citations

Ramirez-Valdez, Ramiro A., Emily Pollock, Federica Cappuccini, et al.. (2021). Heterologous prime-boost vaccination targeting MAGE-type antigens promotes tumor T-cell infiltration and improves checkpoint blockade therapy. Journal for ImmunoTherapy of Cancer. 9(9). e003218–e003218. 16 indexed citations

Hill, Adrian V. S., Mark Tuthill, Federica Cappuccini, et al.. (2021). Abstract IA11: Viral vectored vaccines for prostate cancer. Cancer Immunology Research. 9(2_Supplement). IA11–IA11.

Tuthill, Mark, Federica Cappuccini, Emily Pollock, et al.. (2020). 682P Results from ADVANCE: A phase I/II open-label non-randomised safety and efficacy study of the viral vectored ChAdOx1-MVA 5T4 (VTP-800) vaccine in combination with PD-1 checkpoint blockade in metastatic prostate cancer. Annals of Oncology. 31. S543–S543. 4 indexed citations

Redchenko, Irina, Federica Cappuccini, Emily Pollock, et al.. (2018). VANCE: First-in-human phase I study of a novel ChAdOx1-MVA 5T4 vaccine in low and intermediate risk prostate cancer.. Journal of Clinical Oncology. 36(15_suppl). 3018–3018. 2 indexed citations

10.

Cappuccini, Federica, Emily Pollock, Stephen M. Stribbling, Adrian V. S. Hill, & Irina Redchenko. (2017). 5T4 oncofoetal glycoprotein: an old target for a novel prostate cancer immunotherapy. Oncotarget. 8(29). 47474–47489. 17 indexed citations

11.

Cappuccini, Federica, Stephen M. Stribbling, Emily Pollock, Adrian V. S. Hill, & Irina Redchenko. (2016). Immunogenicity and efficacy of the novel cancer vaccine based on simian adenovirus and MVA vectors alone and in combination with PD-1 mAb in a mouse model of prostate cancer. Cancer Immunology Immunotherapy. 65(6). 701–713. 42 indexed citations

12.

Pollock, Emily. (2015). The effect of β-Estradiol on freshwater algae (Pseudokirchneriella subcapitata). University of Alberta Library. 1. 1 indexed citations

13.

Pollock, Emily, et al.. (2014). Metalloproteinase inhibition prevents inhibitory synapse reorganization and seizure genesis. Neurobiology of Disease. 70. 21–31. 59 indexed citations

14.

Marks, Michael, Emily Pollock, Margaret Armstrong, et al.. (2012). Needles and the damage done: Reasons for admission and financial costs associated with injecting drug use in a Central London Teaching Hospital. Journal of Infection. 66(1). 95–102. 38 indexed citations

15.

Gavrilovici, Cezar, et al.. (2012). The loss of interneuron functional diversity in the piriform cortex after induction of experimental epilepsy. Neurobiology of Disease. 48(3). 317–328. 22 indexed citations

16.

Pollock, Emily, et al.. (2009). Bone health in HIV infection. British Medical Bulletin. 92(1). 123–133. 12 indexed citations

17.

Palmer, Martin, Andrew R. Belch, Larry W. Brox, Emily Pollock, & Maria Koch. (1987). Are the current criteria for response useful in the management of multiple myeloma?. Journal of Clinical Oncology. 5(9). 1373–1377. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact